ATE444946T1 - Verzweigte carbonsäureverbindung und deren verwendung - Google Patents
Verzweigte carbonsäureverbindung und deren verwendungInfo
- Publication number
- ATE444946T1 ATE444946T1 AT04747782T AT04747782T ATE444946T1 AT E444946 T1 ATE444946 T1 AT E444946T1 AT 04747782 T AT04747782 T AT 04747782T AT 04747782 T AT04747782 T AT 04747782T AT E444946 T1 ATE444946 T1 AT E444946T1
- Authority
- AT
- Austria
- Prior art keywords
- carboxylic acid
- parkinson
- integer
- disease
- acid compound
- Prior art date
Links
- -1 CARBOXYLIC ACID COMPOUND Chemical class 0.000 title 1
- 201000008247 brain infarction Diseases 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 206010008118 cerebral infarction Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 206010034010 Parkinsonism Diseases 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 210000001130 astrocyte Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000006764 neuronal dysfunction Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003274988 | 2003-07-15 | ||
| PCT/JP2004/010366 WO2005005366A1 (ja) | 2003-07-15 | 2004-07-14 | 分枝鎖カルボン酸化合物およびその用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE444946T1 true ATE444946T1 (de) | 2009-10-15 |
Family
ID=34056106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04747782T ATE444946T1 (de) | 2003-07-15 | 2004-07-14 | Verzweigte carbonsäureverbindung und deren verwendung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7579375B2 (de) |
| EP (1) | EP1650182B1 (de) |
| JP (1) | JP4788999B2 (de) |
| AT (1) | ATE444946T1 (de) |
| DE (1) | DE602004023510D1 (de) |
| WO (1) | WO2005005366A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| BRPI0619249A2 (pt) | 2005-11-30 | 2011-09-20 | Abbott Lab | anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos |
| PT1976877E (pt) | 2005-11-30 | 2014-04-29 | Abbvie Inc | Anticorpos monoclonais contra proteína beta-amilóide e suas utilizações |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| EP2124952A2 (de) | 2007-02-27 | 2009-12-02 | Abbott GmbH & Co. KG | Verfahren zur behandlung von amyloidosen |
| EP2558494B1 (de) | 2010-04-15 | 2018-05-23 | AbbVie Inc. | Amyloid-beta-bindende proteine |
| CN105348387B (zh) | 2010-08-14 | 2020-08-25 | Abbvie 公司 | β淀粉样蛋白结合蛋白 |
| US8921533B2 (en) | 2011-07-25 | 2014-12-30 | Chromatin Technologies | Glycosylated valproic acid analogs and uses thereof |
| WO2013024028A1 (en) * | 2011-08-12 | 2013-02-21 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compounds and compositions for treating proteinopathies |
| KR101890058B1 (ko) * | 2017-02-21 | 2018-08-21 | 동국대학교 산학협력단 | 신규한 마리올라이드 유도체 및 이를 함유하는 만성 염증성 질환의 예방 또는 치료용 조성물 |
| EP3955905A4 (de) * | 2019-04-18 | 2023-05-31 | Prevep LLC | Therapeutische kombinationen, flüssige pharmazeutische zusammensetzungen, kits zu deren herstellung und verfahren zu deren verwendung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS604182A (ja) | 1983-06-22 | 1985-01-10 | Yamanouchi Pharmaceut Co Ltd | ピリミドン誘導体及びその製法 |
| DE3617177A1 (de) * | 1986-05-22 | 1987-11-26 | Basf Ag | Verfahren zur herstellung von (alpha)-substituierten (gamma)-butyrolactonen |
| JPH04279576A (ja) | 1991-03-07 | 1992-10-05 | Tanabe Seiyaku Co Ltd | 光学活性４−ペンタノライド誘導体の製法 |
| TW248552B (de) * | 1993-06-01 | 1995-06-01 | Onoda Yakuhin Kogyo Kk | |
| CA2453478A1 (en) | 2001-07-18 | 2003-01-30 | Ono Pharmaceutical Co., Ltd. | Agent for treatment of cerebral ischemic diseases |
-
2004
- 2004-07-14 AT AT04747782T patent/ATE444946T1/de not_active IP Right Cessation
- 2004-07-14 WO PCT/JP2004/010366 patent/WO2005005366A1/ja not_active Ceased
- 2004-07-14 DE DE602004023510T patent/DE602004023510D1/de not_active Expired - Lifetime
- 2004-07-14 US US10/564,720 patent/US7579375B2/en not_active Expired - Fee Related
- 2004-07-14 EP EP04747782A patent/EP1650182B1/de not_active Expired - Lifetime
- 2004-07-14 JP JP2005511616A patent/JP4788999B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7579375B2 (en) | 2009-08-25 |
| EP1650182A4 (de) | 2006-10-11 |
| WO2005005366A1 (ja) | 2005-01-20 |
| JPWO2005005366A1 (ja) | 2006-08-24 |
| JP4788999B2 (ja) | 2011-10-05 |
| DE602004023510D1 (de) | 2009-11-19 |
| EP1650182A1 (de) | 2006-04-26 |
| US20070167522A1 (en) | 2007-07-19 |
| EP1650182B1 (de) | 2009-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004020431A3 (en) | Novel benzoimidazole derivatives useful as antiproliferative agents | |
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| DE602005004286D1 (de) | 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyridoä2,3-düpyrimidinderivate und verwandte verbindungen zur behandlung von krebs | |
| UA83899C2 (uk) | Сполуки імідазолу для лікування нейродегенеративних розладів | |
| IL214852A0 (en) | N-substituted-4-heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain and pharmaceutical composition comprising the same | |
| WO2005105732A8 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
| IL195378A0 (en) | Radioactive substituted heterocycle derivative and diagnostic agent for alzheimer's containing it | |
| WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
| MXPA04000411A (es) | Tiazolidinonas arilo sustituidas y uso de las mismas. | |
| IL189762A0 (en) | Isoxazolo derivatives as gaba a alpha5 inverse agonists | |
| IL191935A (en) | The water-soluble benzozepine compound @ and its @pharmaceutical @ preparation | |
| DE602004023510D1 (de) | Verzweigte carbonsäureverbindung und deren verwendung | |
| PL1664041T3 (pl) | Przydatne do leczenia bólu związki fenylowo-karboksyamidowe | |
| PT1648878E (pt) | Compostos de piperidina e composições farmacêuticas que os contêm | |
| SG161217A1 (en) | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents | |
| PT2420491E (pt) | Compostos de piperidina 3,5-substituída como inibidores de renina | |
| MX2009014001A (es) | Derivados de isoxazol-imidazol. | |
| IL194889A0 (en) | Compound having affinity to amyloid | |
| MY138547A (en) | N-substituted nonaryl-heterocyclic nmda/nr2b antagonists | |
| TW200736251A (en) | Aryl-isoxazol-4-yl-imidazole derivatives | |
| EP2127650A3 (de) | Antibakterielle Carbapenem-Mittel mit gram-negativer Wirkung und Herstellungsverfahren dafür | |
| MX2009005242A (es) | Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo. | |
| TW200602297A (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
| TW200745033A (en) | Oxindole derivative as feeding control agent | |
| EP1958939A3 (de) | Pyrazolaminverbindungen zur Behandlung neurodegenerativer Erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |